Results 121 to 130 of about 436,478 (164)

Dose-Escalated Upadacitinib for Refractory Myositis in Anti-Jo-1-Positive Antisynthetase Syndrome: A Case Report. [PDF]

Case Rep Rheumatol
Kukida Y, Inoue H.
europepmc   +1 more source

MacVicker, JAK

, 2016
MacVicker, JAK
core  

Dual-Targeted Therapy in Refractory Pyoderma Gangrenosum: A Focused Systematic Review of Convergent Pathway Targeting. [PDF]

Dermatol Ther (Heidelb)
Shanshal M, Karanasios G.
europepmc   +1 more source

Jak zaakceptować symulakrum

Dziennikarstwo i Media
Dominik Lewiński
doaj   +1 more source

JAK Inhibitors for Treatment of Pyoderma Gangrenosum and Sweet Syndrome: A Systematic Review of Published Case Reports. [PDF]

Dermatol Res Pract
Vahabi SM, Heidari S, Farahmand Y, Pourgholi E, Kianfar N, Memari H, Esmaeili F, Bahramian S, Etesami I, Ansari MS.   +9 more
europepmc   +1 more source

Biologics, Janus Kinase Inhibitors, and Cancer: The Comparator on Trial. [PDF]

Int J Rheum Dis
Chang ST, Hsu TC.
europepmc   +1 more source

Exploring the mechanism of action of tripterygium glycosides tablets in the treatment of rheumatoid arthritis based on the Lnc-ENST00000602558/IGF1 signaling pathway. [PDF]

Front Pharmacol
Fang JY, Liu MX, Yang YN, Xie CX, Liu CP, Zhu CH, Hu J, Li W, Lv L, Wang YH, Zhu ZH, Wang HL.   +11 more
europepmc   +1 more source

Management of BK Polyomavirus in a Kidney Transplant Recipient With Primary Myelofibrosis on JAK-2 Inhibition - A Case Report and Literature Review. [PDF]

Can J Kidney Health Dis
Bywater L, Gill J, Nicholl D.
europepmc   +1 more source

Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series. [PDF]

JGH Open
Vootukuru N, Hilley P, Wong D, Srinivasan A, De Cruz P, Choy M.   +5 more
europepmc   +1 more source